Home
AURA
AURA News

Latest Aura Biosciences Inc. (AURA) News on August 5, 2025

MT Newswires

3 months ago

Aura Biosciences Prices $75 Million Offering of Shares, Warrants

Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants

GlobeNewswire

3 months ago

Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants

MT Newswires

3 months ago

Aura Biosciences Launches Proposed Public Offering of Shares, Warrants

Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants

GlobeNewswire

3 months ago

Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants

Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights

GlobeNewswire

3 months ago

Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights

Aura Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire

3 months ago

Aura Biosciences to Participate in Upcoming Investor Conferences

Is Aura Biosciences (AURA) The Small Cap Stock with Huge Upside Potential?

Insider Monkey

4 months ago

Is Aura Biosciences (AURA) The Small Cap Stock with Huge Upside Potential?

Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors

GlobeNewswire

4 months ago

Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors

Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

GlobeNewswire

4 months ago

Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

MT Newswires

4 months ago

Aura Biosciences Reports 'Robust' Anti-Tumor Immune Response From Phase 1 Trial of Bel-sar in Non-Muscle-Invasive Bladder Cancer

Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress

GlobeNewswire

4 months ago

Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress

With 48% stake, Aura Biosciences, Inc. (NASDAQ:AURA) seems to have captured institutional investors' interest

Simply Wall St.

4 months ago

With 48% stake, Aura Biosciences, Inc. (NASDAQ:AURA) seems to have captured institutional investors' interest

MT Newswires

5 months ago

Top Premarket Gainers

Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress

GlobeNewswire

5 months ago

Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress

Aura Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire

5 months ago

Aura Biosciences to Participate in Upcoming Investor Conferences

Companies Like Aura Biosciences (NASDAQ:AURA) Are In A Position To Invest In Growth

Simply Wall St.

6 months ago

Companies Like Aura Biosciences (NASDAQ:AURA) Are In A Position To Invest In Growth

Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference

GlobeNewswire

8 months ago

Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

9 months ago

Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights

One Aura Biosciences Insider Raised Stake By 232% In Previous Year

Simply Wall St.

9 months ago

One Aura Biosciences Insider Raised Stake By 232% In Previous Year

MT Newswires

9 months ago

Aura Biosciences Insider Sold Shares Worth $300,839, According to a Recent SEC Filing

Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial

GlobeNewswire

10 months ago

Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial

Aura Biosciences, Inc. (NASDAQ:AURA) is a favorite amongst institutional investors who own 58%

Simply Wall St.

10 months ago

Aura Biosciences, Inc. (NASDAQ:AURA) is a favorite amongst institutional investors who own 58%

Aura Stock Up as Lead Drug Shows Superior Efficacy in Eye Cancer Study

Zacks

a year ago

Aura Stock Up as Lead Drug Shows Superior Efficacy in Eye Cancer Study

MT Newswires

a year ago

Sector Update: Health Care Stocks Mixed Pre-Bell Thursday

MT Newswires

a year ago

Aura Biosciences' Eye Cancer Therapy Shows Promise in Mid-Stage Study -- Shares Rise Pre-Bell

Aura Biosciences Reports Positive Phase 2 End of Study Results Evaluating Bel-sar as a First-Line Treatment for Early-Stage Choroidal Melanoma

GlobeNewswire

a year ago

Aura Biosciences Reports Positive Phase 2 End of Study Results Evaluating Bel-sar as a First-Line Treatment for Early-Stage Choroidal Melanoma

MT Newswires

a year ago

LifeSci Initiates Aura Biosciences at Outperform With $23 Price Target

We're Not Very Worried About Aura Biosciences' (NASDAQ:AURA) Cash Burn Rate

Simply Wall St.

a year ago

We're Not Very Worried About Aura Biosciences' (NASDAQ:AURA) Cash Burn Rate

Aura Biosciences to Host a Urologic Oncology Investor Event to Present Early Non-Muscle Invasive Bladder Cancer (NMIBC) Data from its Ongoing Phase 1 Trial on Thursday, October 17, 2024

GlobeNewswire

a year ago

Aura Biosciences to Host a Urologic Oncology Investor Event to Present Early Non-Muscle Invasive Bladder Cancer (NMIBC) Data from its Ongoing Phase 1 Trial on Thursday, October 17, 2024

Aura Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

Aura Biosciences to Participate in Upcoming Investor Conferences

Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal Administration of Bel-sar for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma at The Retina Society Annual Meeting

GlobeNewswire

a year ago

Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal Administration of Bel-sar for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma at The Retina Society Annual Meeting

Aura Biosciences Reports Second Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

a year ago

Aura Biosciences Reports Second Quarter 2024 Financial Results and Business Highlights

MT Newswires

a year ago

HC Wainwright Starts Aura Biosciences With Buy Rating, $21 Price Target

Wall Street Analysts See a 162.63% Upside in Aura Biosciences (AURA): Can the Stock Really Move This High?

Zacks

a year ago

Wall Street Analysts See a 162.63% Upside in Aura Biosciences (AURA): Can the Stock Really Move This High?

Aura Biosciences to Participate in the Jefferies Global Healthcare Conference

GlobeNewswire

a year ago

Aura Biosciences to Participate in the Jefferies Global Healthcare Conference

Aura Biosciences to Host Virtual KOL Event “Pioneering a New Standard of Care In Ocular Oncology” on May 29, 2024

GlobeNewswire

a year ago

Aura Biosciences to Host Virtual KOL Event “Pioneering a New Standard of Care In Ocular Oncology” on May 29, 2024

GuruFocus.com

a year ago

Aura Biosciences Inc (AURA) Reports Q1 2024 Earnings: A Detailed Financial Overview

Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

a year ago

Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights

Aura Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

Aura Biosciences to Participate in Upcoming Investor Conferences

One Aura Biosciences Insider Raised Stake By 232% In Previous Year

Simply Wall St.

a year ago

One Aura Biosciences Insider Raised Stake By 232% In Previous Year

We're Not Very Worried About Aura Biosciences' (NASDAQ:AURA) Cash Burn Rate

Simply Wall St.

a year ago

We're Not Very Worried About Aura Biosciences' (NASDAQ:AURA) Cash Burn Rate

Business Wire

a year ago

Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

11 Oversold Biotech Stocks To Buy Right Now

Insider Monkey

a year ago

11 Oversold Biotech Stocks To Buy Right Now

Business Wire

a year ago

Aura Biosciences to Participate in Upcoming Investor Conferences

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 years ago

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

‘Kubrick’ Review: The Perfectionist and His Craft

The Wall Street Journal

2 years ago

‘Kubrick’ Review: The Perfectionist and His Craft

Mercantile Bank (NASDAQ:MBWM) Is Increasing Its Dividend To $0.35

Simply Wall St.

2 years ago

Mercantile Bank (NASDAQ:MBWM) Is Increasing Its Dividend To $0.35

Analysts Estimate A-Mark Precious Metals (AMRK) to Report a Decline in Earnings: What to Look Out for

Zacks

2 years ago

Analysts Estimate A-Mark Precious Metals (AMRK) to Report a Decline in Earnings: What to Look Out for

Associated Press Finance

2 years ago

Flushing Financial: Q4 Earnings Snapshot

Flushing Financial Corporation Reports 2023 and 4Q23 GAAP EPS of $0.96 and $0.27, and Core EPS of $0.83 and $0.25, Respectively; Continues to Successfully Execute On Its Action Plan

GlobeNewswire

2 years ago

Flushing Financial Corporation Reports 2023 and 4Q23 GAAP EPS of $0.96 and $0.27, and Core EPS of $0.83 and $0.25, Respectively; Continues to Successfully Execute On Its Action Plan

Associated Press Finance

2 years ago

Kearny: Fiscal Q2 Earnings Snapshot

Kearny Financial Corp. Announces Second Quarter Fiscal 2024 Results and Declaration of Cash Dividend

GlobeNewswire

2 years ago

Kearny Financial Corp. Announces Second Quarter Fiscal 2024 Results and Declaration of Cash Dividend

Q3 Earnings Highlights: Carrols (NASDAQ:TAST) Vs The Rest Of The Traditional Fast Food Stocks

StockStory

2 years ago

Q3 Earnings Highlights: Carrols (NASDAQ:TAST) Vs The Rest Of The Traditional Fast Food Stocks

Insider Sell: Cullinan Oncology Inc's Chief Business Officer Corrine Savill Sold 40,000 Shares

GuruFocus.com

2 years ago

Insider Sell: Cullinan Oncology Inc's Chief Business Officer Corrine Savill Sold 40,000 Shares

Piedmont Lithium (PLL) to Sell Portion of Its Atlantic Shares

Zacks

2 years ago

Piedmont Lithium (PLL) to Sell Portion of Its Atlantic Shares

ZORYVE® (roflumilast) Topical Foam, 0.3%, for the Treatment of Seborrheic Dermatitis Launches in the United States

GlobeNewswire

2 years ago

ZORYVE® (roflumilast) Topical Foam, 0.3%, for the Treatment of Seborrheic Dermatitis Launches in the United States

Basic Materials Roundup: Market Talk

The Wall Street Journal

2 years ago

Basic Materials Roundup: Market Talk

Data Analytics Stocks Q3 Highlights: Palantir (NYSE:PLTR)

StockStory

2 years ago

Data Analytics Stocks Q3 Highlights: Palantir (NYSE:PLTR)

Are You Kidding Me? 3 Meme Stocks You Should Have Already Sold

InvestorPlace

2 years ago

Are You Kidding Me? 3 Meme Stocks You Should Have Already Sold

MidWestOne Financial Group, Inc. Announces Fourth Quarter 2023 Earnings Conference Call

GlobeNewswire

2 years ago

MidWestOne Financial Group, Inc. Announces Fourth Quarter 2023 Earnings Conference Call

7 Overlooked Small-Cap Stocks to Keep On Your Radar

InvestorPlace

2 years ago

7 Overlooked Small-Cap Stocks to Keep On Your Radar

NRSInsights’ December 2023 Retail Same-Store Sales Report

GlobeNewswire

2 years ago

NRSInsights’ December 2023 Retail Same-Store Sales Report

Owning 48% shares,institutional owners seem interested in Aura Biosciences, Inc. (NASDAQ:AURA),

Simply Wall St.

2 years ago

Owning 48% shares,institutional owners seem interested in Aura Biosciences, Inc. (NASDAQ:AURA),

Owning 45% shares,institutional owners seem interested in Southern Missouri Bancorp, Inc. (NASDAQ:SMBC),

Simply Wall St.

2 years ago

Owning 45% shares,institutional owners seem interested in Southern Missouri Bancorp, Inc. (NASDAQ:SMBC),

7 Growth Stocks Poised to Thrive in a Post-Fed Pivot World

InvestorPlace

2 years ago

7 Growth Stocks Poised to Thrive in a Post-Fed Pivot World

12 Most Profitable Pot Stocks Now

Insider Monkey

2 years ago

12 Most Profitable Pot Stocks Now

Biotech CEOs Are Buying Up Their Surging Stocks

Barrons.com

2 years ago

Biotech CEOs Are Buying Up Their Surging Stocks

Forge Enhances Institutional Focus with Appointment of Chris Lane

Business Wire

2 years ago

Forge Enhances Institutional Focus with Appointment of Chris Lane

Savara Added to the NASDAQ Biotechnology Index

Business Wire

2 years ago

Savara Added to the NASDAQ Biotechnology Index

Uber Eats Teams Up with Gogoro in Taiwan for Green Delivery Program Worth Nearly $30M

PR Newswire

2 years ago

Uber Eats Teams Up with Gogoro in Taiwan for Green Delivery Program Worth Nearly $30M

IMAX Corporation's (NYSE:IMAX) Business Is Trailing The Industry But Its Shares Aren't

Simply Wall St.

2 years ago

IMAX Corporation's (NYSE:IMAX) Business Is Trailing The Industry But Its Shares Aren't

GlobeNewswire

2 years ago

Village Super Market, Inc. Declares Quarterly Dividend

GeoPark Limited (NYSE:GPRK) is largely controlled by institutional shareholders who own 52% of the company

Simply Wall St.

2 years ago

GeoPark Limited (NYSE:GPRK) is largely controlled by institutional shareholders who own 52% of the company

Wall Street Analysts Think Aura Biosciences, Inc. (AURA) Could Surge 174.29%: Read This Before Placing a Bet

Zacks

2 years ago

Wall Street Analysts Think Aura Biosciences, Inc. (AURA) Could Surge 174.29%: Read This Before Placing a Bet

Business Wire

2 years ago

Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial Evaluating the Safety and Efficacy of Belzupacap Sarotalocan (Bel-sar) for First-Line Treatment of Early-Stage Choroidal Melanoma

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

GlobeNewswire

2 years ago

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

Associated Press Finance

2 years ago

Village Super Market: Fiscal Q1 Earnings Snapshot

GlobeNewswire

2 years ago

Village Super Market, Inc. Reports Results for the First Quarter Ended October 28, 2023

Shareholders in SmartFinancial (NASDAQ:SMBK) are in the red if they invested a year ago

Simply Wall St.

2 years ago

Shareholders in SmartFinancial (NASDAQ:SMBK) are in the red if they invested a year ago

Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services

PR Newswire

2 years ago

Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services

Algoma Steel Announces Retirement of Vice President - Sales

GlobeNewswire

2 years ago

Algoma Steel Announces Retirement of Vice President - Sales

Insider Sell: Executive Vice President Olivier Thirot Sells 30,000 Shares of Kelly Services Inc ...

GuruFocus.com

2 years ago

Insider Sell: Executive Vice President Olivier Thirot Sells 30,000 Shares of Kelly Services Inc ...

Wall Street Analysts Believe Aura Biosciences, Inc. (AURA) Could Rally 200.75%: Here's is How to Trade

Zacks

2 years ago

Wall Street Analysts Believe Aura Biosciences, Inc. (AURA) Could Rally 200.75%: Here's is How to Trade

Rick Hendrick Named Honoree at The Amelia in 2024

PR Newswire

2 years ago

Rick Hendrick Named Honoree at The Amelia in 2024

There's A Lot To Like About GeoPark's (NYSE:GPRK) Upcoming US$0.13 Dividend

Simply Wall St.

2 years ago

There's A Lot To Like About GeoPark's (NYSE:GPRK) Upcoming US$0.13 Dividend

Flagstar Bank sues Hometown Lenders for $21M

Banking Dive

2 years ago

Flagstar Bank sues Hometown Lenders for $21M

A Look At The Intrinsic Value Of Village Super Market, Inc. (NASDAQ:VLGE.A)

Simply Wall St.

2 years ago

A Look At The Intrinsic Value Of Village Super Market, Inc. (NASDAQ:VLGE.A)

GlobeNewswire

2 years ago

Gravity Reports Third Quarter of 2023 Results and Business Updates

David Johnson Bought 232% More Shares In Aura Biosciences

Simply Wall St.

2 years ago

David Johnson Bought 232% More Shares In Aura Biosciences

Business Wire

2 years ago

Aura Biosciences Reports Third Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights

Business Wire

2 years ago

Aura Biosciences to Participate in Upcoming Investor Conferences

Business Wire

2 years ago

Aura Biosciences Announces Pricing of Public Offering of Common Stock

Share on Social Networks: